Medical Decision Making

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here for free access to the SAGE eReference platform!

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nan Luo,
Right arrow Articles by Coons, S. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nan Luo,
Right arrow Articles by Coons, S. J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Medical Decision Making, Vol. 27, No. 3, 321-326 (2007)
DOI: 10.1177/0272989X07300603

A Comparison of EQ-5D Index Scores Derived from the US and UK Population-Based Scoring Functions

Nan Luo, PhD

Centre for Health Services Research, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, medln{at}nus.edu.sg

Jeffrey A. Johnson, PhD

Institute of Health Economics & University of Alberta, Edmonton, Alberta, Canada

James W. Shaw, PhD, PharmD, MPH

Department of Pharmacy Administration and Center for Pharmacoeconomics, College of Pharmacy, University of Illinois at Chicago, Illinois

Stephen Joel Coons, PhD

College of Pharmacy and College of Public Health, University of Arizona, Tucson, Arizona

The authors recently introduced a new preference-based scoring function for the EQ-5D (D1 model) based on time tradeoff valuations from the general adult US population. In this study, they compared the EQ-5D index scores derived from the US (D1) algorithm to the more familiar UK (N3) algorithm. They compared preference-based EQ-5D index scores for all possible EQ-5D health states and differences in EQ-5D index scores between pairs of EQ-5D health states predicted by the D1 and N3 models. The responsiveness of D1- and N3-predicted EQ-5D index scores was assessed using simulated transitions between EQ-5D health states. The mean (SD) EQ-5D index scores for all 243 health states predicted by the D1 and N3 models were 0.37 (0.23) and 0.14 (0.31), respectively. The mean (SD) absolute difference in EQ-5D index scores for all 29,403 pairs of health states was 0.25 (0.19) and 0.35 (0.27), according to the D1 and N3 models, respectively. The D1 and N3 models were consistent in predicting gains/losses for 27,592 (94%) transitions between EQ-5D health state pairs; Cohen effect size, calculated using these 27,592 consistent transitions, was 1.58 and 1.59 for the D1 and N3 models, respectively. Based on these simulation results, it appears that the D1 model would lead to smaller gains in quality-adjusted life years than the N3 model; however, their responsiveness appears to be similar. Empirical studies are needed to examine whether these 2 EQ-5D scoring functions would lead to different conclusions in cost-utility analyses.

Key Words: EQ-5D • health state preferences • health state values • valuation • cost-utility analysis


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Med Decis MakingHome page
W. Miller
The Significance of Using US-Valued EQ-5D Health States for Comparative Effectiveness and Cost-Effectiveness Studies in US Populations
Med Decis Making, May 1, 2007; 27(3): 229 - 230.
[PDF]


Home page
Med Decis MakingHome page
L. B. Russell
Is All Cost-Effectiveness Analysis Local?
Med Decis Making, May 1, 2007; 27(3): 231 - 232.
[PDF]